Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus

Clinica Chimica Acta

Volumn 376, Issue 1-2, 2007, Pages 17-22

  Pérez Méndez, Oscar ^a   Torres Tamayo, Margarita ^b   Posadas Romero, Carlos ^a   Vidaure Garcés, Vladimir ^a   Carreón Torres, Elizabeth ^a   Mendoza Pérez, Enrique ^a   Medina Urrutia, Aida ^a   Huesca Gómez, Claudia ^a   Zamora González, José ^a   Aguilar Herrera, Blanca ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Children; Coronary risk factors; High density lipoproteins; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ASSESSMENT; CLINICAL INDICATOR; COMORBIDITY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GEL ELECTROPHORESIS; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARTICLE SIZE; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MALE; OBESITY; PARTICLE SIZE;

EID: 33845312671     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.07.003     Document Type: Article

References (32)

1. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
2. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., et al. Type 2 diabetes among North American children and adolescents. An epidemiologic review and a public health perspective. J Pediatr 136 (2000) 664-672
3. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., Standford D., Khoury P., and Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128 (1996) 608-615
4. Howard B.V., Mayer-Davis E.J., Goff D., et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 47 (1998) 1174-1179
5. Eckardstein A., Huang Y., and Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 5 (1994) 404-416
6. Tomkin G.H., and Owens D. Insulin and lipoprotein metabolism with special reference to the diabetic state. Diabetes Metab Rev 10 (1994) 225-252
7. Garvey W.T., Kwon S., Zheng D., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003) 453-642
8. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
9. Lamarche B., Tchernof A., Moorjani S., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
10. Williams P.T., Krauss R.M., Nichols A.V., Vranizan K.M., and Wood P.D. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 31 (1990) 1131-1139
11. Deakin S., Leviev I., Gomaraschi M., Calabresi L., Franceschini G., and James R.W. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 277 (2002) 4301-4308
12. Kontush A., Chantepie S., and Chapman M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 23 (2003) 1881-1888
13. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein pathway. Biochemistry 27 (1988) 25-29
14. Bhalodkar N.C., Blum S., Rana T., Kitchappa R., Bhalodkar A.N., and Enas E.A. Comparison of high-density and low-density lipoprotein cholesterol subclasses and sizes in Asian Indian women with Caucasian women from the Framingham Offspring Study. Clin Cardiol 28 (2005) 247-251
15. Yang Y., Yan B., Fu M., Xu Y., and Tian Y. Relationship between plasma lipid concentrations and HDL subclasses. Clin Chim Acta 354 (2005) 49-58
16. Huesca C., Luc G., Duhal N., Lacroix B., Fruchart J., and Perez-Mendez O. Ciprofibrate increases synthesis and catabolism of HDL apo AI and AII in patients with hypertriglyceridemia (Abstract). Atherosclerosis Suppl 5 (2004) 64
17. Carreón-Torres E., Juárez-Meavepeña M., Cardoso-Saldaña G., et al. Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand white rabbit. Atherosclerosis 181 (2005) 233-240
18. Festa A., Williams K., Hanley A.J., et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111 (2005) 3465-3472
19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
20. www.cdc.gov/nccdphp/dnpa/bmi/childrens_BMI/about_childrens_BMI.htm.
21. DeLong D.M., DeLong E.R., Wood P.D., Lippel K., and Rifkind B.M. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 256 (1986) 2372-2377
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
23. Huesca-Gómez C., Franco M., Luc G., et al. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 51 (2002) 443-450
24. Huesca-Gómez C., Torres-Carreón E., Nepomuceno-Mejía T., et al. Contribution of cholesteryl ester transfer protein and lecithin: cholesterol acyl transferase to HDL size distribution. Endocrinol Res 30 (2004) 403-415
25. MacLean P.S., Bower J.F., Vadlamudi S., Green T., and Barakat H.A. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans. Obes Res 8 (2000) 62-70
26. Otvos J.D., Jeyarajah E.J., Bennett D.W., and Krauss R.M. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38 (1992) 1632-1638
27. Freedman D.S., Bowman B.A., Srinivasan S.R., Berenson G.S., and Otvos J.D. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism 50 (2000) 370-376
28. Freedman D.S., Otvos J.D., Jeyarajah E.J., et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 50 (2004) 1189-1200
29. Morgan J., Carey C., Lincoff A., and Capuzzi D. High-density lipoprotein subfractions and risk of coronary artery disease. Curr Atheroscler Rep 6 (2004) 359-365
30. Freedman D.S., Otvos J.D., Jeyarajah E.J., Barboriak J.J., Anderson A.J., and Walker J.A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18 (1998) 1046-1053
31. Asztalos B.F., Cupples L.A., Demissie S., et al. HDL subpopulations profile and CHD-prevalence in male participants of the Framingham offspring study. Arterioscler Thromb Vasc Biol 24 (2004) 2181-2187
32. Asztalos B.F., Collins D., Cupples L.A., Demissie S., Horvath K.V., and Bloomfield H.E. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 25 (2005) 2185-2191